Td Asset Management Inc Axonics, Inc. Transaction History

Td Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$50.01 - $73.35 $374,924 - $549,904	-7,497 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$51.39 - $66.9 $204,583 - $266,328	-3,981 Reduced 34.68%	7,497 $509,000
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $64,913 - $79,114	1,321 Added 13.01%	11,478 $687,000
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $33,752 - $41,200	800 Added 8.55%	10,157 $507,000
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $214,368 - $372,689	9,357 New	9,357 $329,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.